文献速递胰腺与胆道疾病消化内镜

导丝直径对ERCP结局的影响:0.025英寸与0.035英寸导丝的多中心随机对照试验

The impact of wire caliber on ERCP outcomes: a multicenter randomized controlled trial of 0.025-inch and 0.035-inch guidewires.
PubMed 文献 · Gastrointest Endosc · 2018-01-06

在亚太地区9个高容量三级转诊中心开展随机单盲前瞻性多中心试验,纳入710例乳头完整、常规解剖且胰头或壶腹部无恶性肿瘤的ERCP患者,比较0.025英寸与0.035英寸导丝。两组首要导丝引导胆管插管成功率相似(80.7% vs 80.3%,P=.90),ERCP后胰腺炎(PEP)发生率无显著差异(7.8% vs 9.3%,P=.51),次要结局亦无差异。

要点

  • 0.025英寸与0.035英寸导丝的首要导丝引导胆管插管成功率相似(80.7% vs 80.3%,P=.90)。
  • 两组PEP发生率无显著差异(7.8% vs 9.3%,P=.51)。
  • 两组次要结局均无差异。

核心结论

  • 使用0.025英寸与0.035英寸导丝时,插管成功率和PEP发生率相似。

研究设计与样本

  • 随机、单盲、前瞻性、多中心试验,在亚太地区9个高容量三级转诊中心开展。
  • 纳入710例乳头完整、常规解剖且胰头或壶腹部无恶性肿瘤的ERCP患者。
  • ERCP采用标准化插管算法,患者随机分配至0.025英寸或0.035英寸导丝组。
  • 主要结局为导丝引导插管成功率和PEP发生率,同时研究总体插管成功率和ERCP不良事件。

主要发现

  • 首要导丝引导胆管插管成功率在0.025英寸组为80.7%,在0.035英寸组为80.3%(P=.90)。
  • PEP发生率在0.025英寸组为7.8%,在0.035英寸组为9.3%(P=.51)。
  • 次要结局未见差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Wire-guided biliary cannulation has been demonstrated to improve cannulation rates and reduce post-ERCP pancreatitis (PEP), but the impact of wire caliber has not been studied. This study compares successful cannulation rates and ERCP adverse events by using a 0.025-inch and 0.035-inch guidewire. METHODS: A randomized, single blinded, prospective, multicenter trial at 9 high-volume tertiary-care referral centers in the Asia-Pacific region was performed. Patients with an intact papilla and conventional anatomy who did not have malignancy in the head of the pancreas or ampulla and were undergoing ERCP were recruited. ERCP was performed by using a standardized cannulation algorithm, and patients were randomized to either a 0.025-inch or 0.035-inch guidewire. The primary outcomes of the study were successful wire-guided cannulation and the incidence of PEP. Overall successful cannulation and ERCP adverse events also were studied. RESULTS: A total of 710 patients were enrolled in the study. The primary wire-guided biliary cannulation rate was similar in 0.025-inch and 0.035-inch wire groups (80.7% vs 80.3%; P = .90). The rate of PEP between the 0.025-inch and the 0.035-inch wire groups did not differ significantly (7.8% vs 9.3%; P = .51). No differences were noted in secondary outcomes. CONCLUSION: Similar rates of successful cannulation and PEP were demonstrated in the use of 0.025-inch and 0.035-inch guidewires. (Clinical trial registration number: NCT01408264.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Bassan MS, Sundaralingam P, Fanning SB, et al. The impact of wire caliber on ERCP outcomes: a multicenter randomized controlled trial of 0.025-inch and 0.035-inch guidewires. Gastrointest Endosc. 2018. PMID: 29317269. doi:10.1016/j.gie.2017.11.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。